TMEM184C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.768800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.229000E-01
Normal-vs-Stage2
7.760200E-01
Normal-vs-Stage3
3.320800E-01
Normal-vs-Stage4
2.131600E-01
Stage1-vs-Stage2
7.809000E-01
Stage1-vs-Stage3
2.066000E-01
Stage1-vs-Stage4
1.990350E-01
Stage2-vs-Stage3
2.952800E-01
Stage2-vs-Stage4
2.598100E-02
Stage3-vs-Stage4
7.547800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.967400E-01
Normal-vs-AfricanAmerican
4.011600E-01
Normal-vs-Asian
7.538000E-01
Caucasian-vs-AfricanAmerican
2.889800E-01
Caucasian-vs-Asian
2.653800E-01
AfricanAmerican-vs-Asian
1.534990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.981800E-01
Normal-vs-Female
7.502400E-01
Male-vs-Female
7.900600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.437000E-01
Normal-vs-Age(41-60Yrs)
4.658200E-01
Normal-vs-Age(61-80Yrs)
9.462000E-01
Normal-vs-Age(81-100Yrs)
8.829600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.914800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.403400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.856000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.641710E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.876200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.619200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.230800E-01
Normal-vs-Daily Drinker
6.790400E-01
Normal-vs-Weekly Drinker
9.558400E-01
Normal-vs-Occasional Drinker
5.156000E-01
Normal-vs-Social Drinker
5.775600E-01
Non Drinker-vs-Daily Drinker
9.771200E-01
Non Drinker-vs-Weekly Drinker
5.321800E-01
Non Drinker-vs-Occasional Drinker
1.915900E-02
Non Drinker-vs-Social Drinker
3.970000E-02
Daily Drinker-vs-Weekly Drinker
6.004600E-01
Daily Drinker-vs-Occasional Drinker
4.296000E-02
Daily Drinker-vs-Social Drinker
7.616500E-02
Weekly Drinker-vs-Occasional Drinker
2.456000E-01
Weekly Drinker-vs-Social Drinker
3.297400E-01
Occasional Drinker-vs-Social Drinker
8.823600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.807900E-02
Normal-vs-Grade 2
2.067600E-02
Normal-vs-Grade 3
1.350480E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.697200E-01
Grade 1-vs-Grade 3
2.954000E-01
Grade 1-vs-Grade 4
7.807900E-02
Grade 2-vs-Grade 3
3.387600E-01
Grade 2-vs-Grade 4
2.067600E-02
Grade 3-vs-Grade 4
1.350480E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.826200E-01
Normal-vs-NonDiabetic
8.831400E-01
Diabetic-vs-NonDiabetic
7.090000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.923400E-01
Normal-vs-NoPancreatitis
8.537400E-01
Pancreatitis-vs-NoPancreatitis
1.217790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.597200E-01
Normal-vs-N1
7.119800E-01
N0-vs-N1
5.768400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.581000E-01
Normal-vs-TP53-NonMutant
6.595600E-01
TP53-Mutant-vs-TP53-NonMutant
3.265200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
